Resources for journalists, editors, and media professionals covering healthcare innovation, hyperbaric medicine, and medical device technology.
Company Valuation
Physician Investors
FDA Submission Target
Stay updated with the latest interviews, news, and insights from RxAir360
Join Founder & CEO Diallo M. Watts, Sr. and Chief Strategy Officer Tony Brown as they discuss: "Hyperbaric oxygen therapy shouldn't be limited to 1,300 facilities in America. Why closing this access gap matters — especially for the communities that need it most."
WLIT 106 FM • "The Mornin' Experience" with Marquis Lupton
RxAir360 | National Research Brief
"Geographic Disparities in Access to Hyperbaric Oxygen Therapy in
the United States"
A national infrastructure analysis covering rural access gaps,
legislative impacts, and the path to community-based deployment.
Join industry leaders and healthcare executives for an exclusive round table discussion on the future of hyperbaric medicine. April 2026.
RSVP InterestSubscribe to our media list to get the latest news, interview links, and announcements delivered directly to your inbox.
High-resolution images of the RxAir360 chamber and system components for media use.
RxAir360 Monoplace Chamber System
FDA Pending • Community-Ready Design
Primary Logo
Wordmark
All Assets
Use this version everywhere a short bio is needed.
Diallo M. Watts, Sr. is the Founder and CEO of RxAir360 Inc., a medical technology company focused on expanding access to hyperbaric oxygen therapy by bringing HBOT into physician practice environments. A trained electrical engineer with more than 25 years of experience in engineering, entrepreneurship, and executive leadership, he leads the company's regulatory, engineering, and commercialization strategy. Under his leadership, RxAir360 has raised more than $3.65 million in early-stage funding and is advancing a patented hyperbaric oxygen therapy system designed for integration within physician offices.
Media Contact Email
Phone
(240) 640-4560
March 2026: "The Mornin' Experience" - WLIT 106 FM (with Tony Brown, CSO)
Topic: Geographic Disparities in Access to Hyperbaric Oxygen Therapy
Education
B.S. Electrical Engineering, Morgan State University
Location
Bellaire, Texas (HQ)
For use in articles, press releases, and media coverage
RxAir360 Inc. is a development-stage medical technology company developing hyperbaric oxygen therapy (HBOT) systems for physician offices, pending FDA 510(k) clearance.
RxAir360 Inc. is a Bellaire, Texas-based medical technology company developing innovative hyperbaric oxygen therapy (HBOT) systems designed specifically for physician offices. Unlike traditional hyperbaric chambers requiring large hospital spaces, the RxAir360 vertical monoplace system fits within a standard exam room, rides a standard elevator, and requires no facility renovation. The company has filed Form 211 for OTC market qualification and is advancing toward FDA 510(k) clearance. RxAir360 is backed by 191 investors including physicians, self-directed IRA holders, and accredited individuals. The device is not yet cleared by the FDA and is not available for sale or clinical use.
For interview requests, image assets, executive bios, or additional background, please contact our media relations team.
Contact Media RelationsRxAir360 requests that any coverage of the company accurately reflect the pre-clearance status of the device and not represent it as commercially available. The RxAir360 chamber has not received FDA 510(k) clearance.
Company Name
RxAir360 Inc.
Founded
2022
Headquarters
Bellaire, Texas (Houston area)
Incorporation
Delaware Corporation
Stage
Pre-revenue, development-stage medical technology company
Product
First vertically-oriented monoplace hyperbaric oxygen therapy chamber designed for physician offices
Regulatory Status
FDA 510(k) submission in progress; clearance anticipated 2026
Patent
Issued 2023; 18+ years of protection remaining
Market Maker
Glendale Securities, Inc.
Transfer Agent
Dynamic Stock Transfer, Inc.
Securities Counsel
The Parsons Law Firm
OTC Markets
Form 211 filed
For press inquiries, interview requests, or additional information
Press Contact - 480 Advisors
Response Time
We typically respond to media inquiries within 24-48 hours
Photography
High-resolution images available upon request
Interviews
CEO available for print, broadcast, and podcast interviews
Quotes & Attribution
Please contact us for approval before publishing quotes
Fact Verification
We're happy to verify facts and review technical details